Which of the following drug should be given in sustained release oral dosage form
**Core Concept**
The question requires understanding of **pharmacokinetics** and **drug delivery systems**, specifically the use of **sustained release oral dosage forms** to maintain therapeutic drug levels over a prolonged period.
**Why the Correct Answer is Right**
Since the correct answer is not provided, let's discuss the concept. Drugs that are often given in sustained release forms are those with **short half-lives**, requiring frequent dosing to maintain efficacy, or those that cause **side effects** when given in immediate release form. Sustained release formulations can improve **patient compliance** and reduce **peak-to-trough fluctuations**.
**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific drug, it's hard to assess, but typically, drugs with long half-lives don't require sustained release.
**Option B:** Similarly, without specifics, it's challenging to determine, but drugs with narrow therapeutic indexes might not be ideal for sustained release without careful monitoring.
**Option C:** Again, lacking specifics, but generally, drugs that are well-tolerated in immediate release forms might not necessitate sustained release formulations.
**Option D:** Same as above, without knowing the drug, it's difficult to say, but drugs with significant first-pass metabolism might not be suitable for oral sustained release.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that **sustained release** formulations are particularly useful for drugs like **theophylline**, **nifedipine**, and **verapamil**, which have **narrow therapeutic indexes** or cause **significant side effects** at peak levels, improving both efficacy and tolerability.
**Correct Answer:** Not provided in the query.